Showing results (1901-1910 of 2,149) with videos related to
Sort By:
Pageof 215
Journal of Ovarian Research|April 9, 2013
Serum agonistic autoantibodies against type-1 angiotensin II receptor titer in patients with epithelial ovarian cancer: a potential role in tumor cell migration and angiogenesisLi Song, Su-Li Zhang, Ke-Hua Bai, et al.Journal of Ovarian Research|February 6, 2013
Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovaryTakashi Yamada, Takayoshi Kanda, Hiroshi Mori, et al.Journal of Ovarian Research|February 9, 2013
Massive edema of ovary with cytogenetic alteration of chromosome 12q13-15 in adolescent patient: a case reportRossella De Cecio, Monica Cantile, Nicola Fortunato, et al.Journal of Ovarian Research|February 14, 2013
CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgeryFang Wang, Yanfen Ye, Xia Xu, et al.Journal of Ovarian Research|April 17, 2013
Leiomyosarcoma of the rectum mimicking primary ovarian carcinoma: a case reportYung-Taek Ouh, Jin Hwa Hong, Kyung-Jin Min, et al.Journal of Ovarian Research|April 20, 2013
Developmental potential of human oocytes matured in vitro followed by vitrification and activationPatrick Imesch, David Scheiner, Min Xie, et al.Journal of Ovarian Research|September 12, 2013
Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse modelAndrew J Wilson, Whitney Barham, Jeanette Saskowski, et al.Journal of Ovarian Research|November 21, 2013
Targeted gene silencing using a follicle-stimulating hormone peptide-conjugated nanoparticle system improves its specificity and efficacy in ovarian clear cell carcinoma in vitroShanshan Hong, Xiaoyan Zhang, Jun Chen, et al.Journal of Ovarian Research|October 10, 2013
Antisense oligonucleotide suppression of human IGF-1R inhibits the growth and survival of in vitro cultured epithelial ovarian cancer cellsJie Tang, Junjun Li, Guqing Zeng, et al.Journal of Ovarian Research|December 1, 2012
Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxelStephen R Armstrong, Rashmi Narendrula, Baoqing Guo, et al.Pageof 215